Assignee
SANYOU BIOPHARMACEUTICALS CO LTD
CN·1 granted patent·6 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
7 records- 0148US2026028402A1Anti-cd100 antibody and use thereofSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0242US2025043016A1Tnfr2 binding molecule and use thereofSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0341US2025177546A1Ror1-targeted binding molecule and use thereofSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0436US2024247060A1Cldn18.2 binding molecules and use thereofSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0536US2023002494A1Pd-l1 binding moleculeSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0635US12595302B2CLDN18.2 binding moleculeSANYOU BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Apr 7, 2026·0 cites·12 claims
- 0729US2024092891A1Molecule Specifically Binding to CLDN18.2SANYOU BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SANYOU BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →